Cargando…

Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia

We compared the relationships of alcoholic fatty liver and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia. Using a nationwide Japanese survey, we collected data on subjects with biopsy-proven alcoholic fatty liver or nonalcoholic fatty liver. Multiple logistic regres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toshikuni, Nobuyuki, Fukumura, Atsushi, Hayashi, Nobuhiko, Nomura, Tomoe, Tsuchishima, Mutsumi, Arisawa, Tomiyasu, Tsutsumi, Mikihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	the Society for Free Radical Research Japan 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541424/ https://www.ncbi.nlm.nih.gov/pubmed/23341703 http://dx.doi.org/10.3164/jcbn.12-55

Ejemplares similares

Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis
por: Toshikuni, Nobuyuki, et al.
Publicado: (2017)

Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease
por: Hayashi, Nobuhiko, et al.
Publicado: (2013)

Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus Infection
por: Matsue, Yasuhiro, et al.
Publicado: (2015)

Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma
por: Toshikuni, Nobuyuki, et al.
Publicado: (2013)

An Image Fusion System for Estimating the Therapeutic Effects of Radiofrequency Ablation on Hepatocellular Carcinoma
por: Toshikuni, Nobuyuki, et al.
Publicado: (2017)

The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people
por: KINOSHITA, Kaori, et al.
Publicado: (2019)

Fractionation of gamma-glutamyltransferase in patients with nonalcoholic fatty liver disease and alcoholic liver disease
por: Sueyoshi, Shigeo, et al.
Publicado: (2016)

Serum Endocan as a Novel Prognostic Biomarker in Patients with Hepatocellular Carcinoma
por: Ozaki, Kazuaki, et al.
Publicado: (2014)

MMP‐13 deletion decreases profibrogenic molecules and attenuates N‐nitrosodimethylamine‐induced liver injury and fibrosis in mice
por: George, Joseph, et al.
Publicado: (2017)

Alteration of Trace Elements during Pathogenesis of N-Nitrosodimethylamine Induced Hepatic Fibrosis
por: George, Joseph, et al.
Publicado: (2019)

Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis
por: George, Joseph, et al.
Publicado: (2019)

Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol
por: Yamada, Masayoshi, et al.
Publicado: (2011)

Influence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosa
por: Arisawa, Tomiyasu, et al.
Publicado: (2012)

Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium
por: Nomura, Tomoe, et al.
Publicado: (2013)

Surgical implantation of human adipose derived stem cells attenuates experimentally induced hepatic fibrosis in rats
por: Nomura, Masateru, et al.
Publicado: (2022)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy
por: Zhang, Qing-Qing, et al.
Publicado: (2015)

Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease
por: Martin, Anna, et al.
Publicado: (2022)

Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa
por: Takano, Hikaru, et al.
Publicado: (2020)

Influence of MIF polymorphisms on CpG island hyper-methylation of CDKN2A in the patients with ulcerative colitis
por: Sakurai, Naoko, et al.
Publicado: (2020)

Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis †
por: Yamashita, Shizuya, et al.
Publicado: (2023)

Genetic polymorphisms of MAFK, encoding a small Maf protein, are associated with susceptibility to ulcerative colitis in Japan
por: Arisawa, Tomiyasu, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Dharmalingam, Mala, et al.
Publicado: (2018)

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
por: Patel, Preya J., et al.
Publicado: (2017)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
por: Choi, Jong Hwa, et al.
Publicado: (2020)

Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no?
por: Protopapas, Adonis A., et al.
Publicado: (2021)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
por: Park, Ji-Won, et al.
Publicado: (2023)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Effects of body composition and liver function after long-term pemafibrate treatment on dyslipidemia-associated non-alcoholic fatty liver disease
por: Ishikawa, Toru, et al.
Publicado: (2023)

The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Kosmalski, Marcin, et al.
Publicado: (2022)

Durvalumab-induced Immune-related Hepatitis in a Patient with Non-small Cell Lung Cancer
por: Nakamura, Masakatsu, et al.
Publicado: (2020)

New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
por: Matsuzaka, Takashi, et al.
Publicado: (2020)

Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease
por: Kwon, Inbeom, et al.
Publicado: (2019)

Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus
por: Yamane, Ryosuke, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data
por: Mavrogiannaki, A. N., et al.
Publicado: (2013)

Influence of increased physical activity without body weight loss on hepatic inflammation in patients with nonalcoholic fatty liver disease
por: Asada, Fuminari, et al.
Publicado: (2020)

Impact of thyroid cancer on the cancer risk in patients with non-alcoholic fatty liver disease or dyslipidemia
por: Ho, Joon, et al.
Publicado: (2023)

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Sumida, Yoshio, et al.
Publicado: (2020)

Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
por: Jung, Un Ju, et al.
Publicado: (2014)

Endoscopic and Histological Features of the Large Intestine in Patients with Atopic Dermatitis
por: Arisawa, Tomiyasu, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ifuovd4f7t94cs7bl95c4bg6av